COMP <GO>

BLSM vs CRMD // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

BlossomHill Therapeutics Inc. (NASDAQ) VS. CorMedix Inc. (NASDAQ) • 15-METRIC TALLY: BLSM 1 — CRMD 1

■ METRIC PARITY

LAST: $12.42 (-9.67%) • MKT CAP: $437.0M

options-implied-move

—

LAST: $5.39 (-5.36%) • MKT CAP: $443.9M

options-implied-move

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLSM VS. CRMD) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	BLSM	CRMD	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	88.50%	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	—	45.50%	—	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	—	3.0x	—	TIE	/valuation <GO>
Free Cash Flow Yield	—	—	—	TIE	/fcf-yield <GO>
Operating Margin	—	48.20%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	52.30%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	180.00%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	1.81	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	—	8/9	—	TIE	/piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	39.9	37.1	+2.80	BLSM	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	3.5x	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$437.0M	$443.9M	-$6.9M	CRMD	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	BLSM REV	CRMD REV	BLSM GROSS %	CRMD GROSS %	BLSM FCF	CRMD FCF
FY 2025	$68.4M	$311.7M	—	88.5%	—	$172.8M
FY 2024	—	$43.5M	—	92.7%	—	-$50.7M
FY 2023	—	$137.1M	—	—	—	-$38.4M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

BLSM // BETA —

CRMD // BETA —